药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Natamycin
Sevoflurane
The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Clarithromycin.
Natamycin
Orphenadrine
The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Clarithromycin.
Natamycin
Perhexiline
The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Clarithromycin.
Natamycin
Felbamate
The risk or severity of QTc prolongation can be increased when Felbamate is combined with Clarithromycin.
Natamycin
Brompheniramine
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Brompheniramine.
Natamycin
Inotersen
The risk or severity of QTc prolongation can be increased when Inotersen is combined with Clarithromycin.
Natamycin
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Clarithromycin.
Natamycin
Rufloxacin
The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Clarithromycin.
Natamycin
Piromidic acid
The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Clarithromycin.
Natamycin
Lorajmine
The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Clarithromycin.
Natamycin
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Clarithromycin.
Natamycin
Prajmaline
The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Clarithromycin.
Natamycin
Cibenzoline
The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Clarithromycin.
Natamycin
Cicletanine
The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Clarithromycin.
Natamycin
Pilsicainide
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Clarithromycin.
Natamycin
Givinostat
The risk or severity of QTc prolongation can be increased when Givinostat is combined with Clarithromycin.
Natamycin
Temefos
The risk or severity of QTc prolongation can be increased when Temefos is combined with Clarithromycin.
Natamycin
Delafloxacin
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Clarithromycin.
Natamycin
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Clarithromycin.
Natamycin
CUDC-907
The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Clarithromycin.